Glycans in Diseases and Therapeutics

Glyco-epitope diversity enhances the role of glycans and is now considered essential for life, both under normal and pathological conditions. The vital role of glycans in the research and development of diseases and the possible therapeutic use of this class of molecules by describing how the interaction of glycans with growth factors, extracellular proteases ,growth factor binding proteins, protease inhibitors, chemokines, morphogens, and adhesive proteins regulates inflammation, infection, atherosclerosis,  cancer, thrombosis and embryonic stem cell biology.

  • Genetic disorder of glycosylations
  • Growth factors and oncogenes
  • Glycoprotein ligand
  • Genetically engineered glycan

Related Conference of Glycans in Diseases and Therapeutics

July 13-14, 2018

13th International Conference on Structural Biology

Toronto | Ontario | Canada
August 16-17, 2018

5th Annual Congress on Plant & Soil Science

London, UK
August 27-28, 2018

5th International Conference on Glycobiology, Lipids & Proteomics

Toronto, Ontario, Canada
August 27-28, 2018

3rd International Conference on Molecular Biology & Nucleic Acids

Toronto, Ontario, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018

4th International Conference on Biochemistry & Biophysics

Los Angeles, California, USA
Nov 19-20, 2018

15th World Congress on Structural Biology

Lisbon, Portugal
December 05-06, 2018

4th International Conference on Genetic and Protein Engineering

Chicago, Illinois, USA

Glycans in Diseases and Therapeutics Conference Speakers